“Distribution of serum amylase levels in patients with cutaneous leishmaniasis treated with meglumina antimoniate”, Univ. Med., vol. 53, no. 1, pp. 33–42, Apr. 2016, doi: 10.11144/Javeriana.umed53-1.dnsa.